Telehealth Companies Expand GLP-1 Prescribing Amid Safety and Oversight Concerns
Telehealth companies are rapidly expanding access to GLP-1 weight loss medications in response to surging demand. Researchers and physicians report concerns that some online providers lack adequate patient screening and monitoring protocols for these medications. The criticism comes as telehealth prescribing of GLP-1s becomes a significant business model for digital health companies. The safety and oversight questions could prompt regulatory scrutiny of telehealth prescribing practices.
Medicaid managed care organizations covering GLP-1s through telehealth arrangements face potential utilization management, quality oversight, and pharmacy cost implications if screening and monitoring standards are inconsistent across providers.
Pharmacy · Managed Care
You might also like